Lv1
90 积分 2024-09-02 加入
Digital Twin: Benefits, use cases, challenges, and opportunities
6天前
已完结
Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials
6天前
已完结
Next generation prophylactic human papillomavirus vaccines
14天前
已完结
Human papillomavirus genotype attribution for HPVs 6,11,16,18,31,33,45,52 and 58 in female anogenital lesions
14天前
已完结
Chapter 12: Prophylactic HPV vaccines: Underlying mechanisms
1个月前
已完结
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
1个月前
已完结
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
1个月前
已完结
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial
2个月前
已完结
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
2个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
2个月前
已完结
皖公网安备34019202002308
